136 related articles for article (PubMed ID: 6601312)
1. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.
Pollack MS; Safai B; Myskowski PL; Gold JW; Pandey J; Dupont B
Tissue Antigens; 1983 Jan; 21(1):1-8. PubMed ID: 6601312
[TBL] [Abstract][Full Text] [Related]
2. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5.
Melbye M; Kestens L; Biggar RJ; Schreuder GM; Gigase PL
Int J Cancer; 1987 Feb; 39(2):182-4. PubMed ID: 3492448
[TBL] [Abstract][Full Text] [Related]
3. Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma.
Papasteriades C; Kaloterakis A; Filiotou A; Economidou J; Nicolis G; Trichopoulos D; Stratigos J
Tissue Antigens; 1984 Nov; 24(5):313-5. PubMed ID: 6335794
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DR5 with mycosis fungoides.
Safai B; Myskowski PL; Dupont B; Pollack MS
J Invest Dermatol; 1983 May; 80(5):395-7. PubMed ID: 6601679
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group.
Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G
Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573
[TBL] [Abstract][Full Text] [Related]
6. HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma.
Prince HE; Schroff RW; Ayoub G; Han S; Gottlieb MS; Fahey JL
J Clin Immunol; 1984 May; 4(3):242-5. PubMed ID: 6588054
[TBL] [Abstract][Full Text] [Related]
7. HLA and Kaposi's sarcoma in Sardinia.
Contu L; Cerimele D; Pintus A; Cottoni F; La Nasa G
Tissue Antigens; 1984 Apr; 23(4):240-5. PubMed ID: 6587615
[TBL] [Abstract][Full Text] [Related]
8. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries.
Martinetti M; Tinelli C; Kolek V; Cuccia M; Salvaneschi L; Pasturenzi L; Semenzato G; Cipriani A; Bartova A; Luisetti M
Am J Respir Crit Care Med; 1995 Aug; 152(2):557-64. PubMed ID: 7633707
[TBL] [Abstract][Full Text] [Related]
9. Interplay of immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis.
Stenszky V; Kozma L; Szegedi G; Farid NR
J Immunogenet; 1986 Feb; 13(1):11-7. PubMed ID: 3091700
[TBL] [Abstract][Full Text] [Related]
10. HLA and Gm genes in systemic lupus erythematosus.
Whittingham S; Mathews JD; Schanfield MS; Tait BD; Mackay IR
Tissue Antigens; 1983 Jan; 21(1):50-7. PubMed ID: 6404002
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
13. HLA in familial and nonfamilial Mediterranean Kaposi's sarcoma in Greece.
Kaloterakis A; Papasteriades C; Filiotou A; Economidou J; Hadjiyannis S; Stratigos J
Tissue Antigens; 1995 Feb; 45(2):117-9. PubMed ID: 7792757
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma and the HLA-Dr5 alloantigen.
Ohara N; Chang SW
Ann Intern Med; 1982 Oct; 97(4):617. PubMed ID: 6982016
[No Abstract] [Full Text] [Related]
15. HLA and Kaposi's sarcoma in solid organ transplantation.
Brunson ME; Balakrishnan K; Penn I
Hum Immunol; 1990 Sep; 29(1):56-63. PubMed ID: 2211190
[TBL] [Abstract][Full Text] [Related]
16. Immunologic and immunogenetic features of primary Kaposi's sarcoma.
Marinig C; Fiorini G; Boneschi V; Melotti E; Brambilla L
Cancer; 1985 May; 55(9):1899-901. PubMed ID: 3156665
[TBL] [Abstract][Full Text] [Related]
17. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).
Lynch CJ; Singh G; Whiteside TL; Rodnan GP; Medsger TA; Rabin BS
J Clin Immunol; 1982 Oct; 2(4):314-8. PubMed ID: 6982903
[TBL] [Abstract][Full Text] [Related]
18. HLA antigen frequencies in HIV-1-related Kaposi's sarcoma.
Mann DL; Murray C; O'Donnell M; Blattner WA; Goedert JJ
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S51-5. PubMed ID: 2395088
[TBL] [Abstract][Full Text] [Related]
19. [HLA typing in classical and African Kaposi's disease].
Lemarchand-Venencie F; Lepace V; Belaich S; Civatte J; Rabian C; Chidiac A; Colombani J; Degos L
Pathol Biol (Paris); 1986 Jun; 34(6):761-4. PubMed ID: 3531992
[TBL] [Abstract][Full Text] [Related]
20. [T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].
Kuntz BM; Sobieraj B; Brüster HT
Beitr Infusionsther Transfusionsmed; 1994; 32():310-3. PubMed ID: 9480115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]